Tag: uva health system (Page 3)
Providing Greater Options for Cervical Spine Patients
Spine fusion has its advantages, however, within the last decade, cervical disc replacement has gained traction as an alternative for some patients.
Your UVA Physician Directory Is Now a Searchable, Multifunctional App
The printed physician directory is being phased out in favor of a new UVA Doctors app that allows you to easily find the UVA specialist you’re looking for.
Meet Your UVA Schedulers
The UVA scheduling team will host an open house where you'll have an opportunity to meet the team and provide feedback on your access experience.
UVA Pediatric Oncologist Makes Top 10 for Research Advancing CAR T-cell Therapies for Leukemia
The Clinical Research Forum recognized Daniel Trey Lee, MD, for his efforts to genetically modify a patient’s own immune cells to identify and kill cancer cells.
Connect with Colleagues at UVA Spring Sporting Events
UVA Health System invites you to join us at one of our networking events this year.
Get to Know: Hematologist Louise Man, MD
A former UVA fellow, Man specializes in the treatment of patients with non-malignant blood disorders, including disorders of clotting and bleeding, such as hemophilia.
Tailoring Neurosurgery to Meet the Unique Needs of Pediatric Patients
Although minimally invasive surgery is now utilized regularly among all age groups, it is especially beneficial for babies and young children.
Together We Can Help Prevent Readmissions After Joint Replacement Surgery
Partnering with referring providers to ensure patients are medically optimized prior to joint replacement surgery is key to preventing readmissions.
Get to Know: Chair of Dermatology, Arturo P. Saavedra, MD, PhD, MBA, FAAD
Dr. Saavedra specializes in the diagnosis and care of complex medical dermatology, and his clinical interests include HIV dermatology, severe drug reactions that manifest with dermatologic complications, and care of oncologic and post-transplant patients.
Helping Patients Navigate Precision Breast IORT Study
The Phase II study has enrolled 120 women ages 45 and older with stage 0 or stage 1 breast cancer. Recruitment is ongoing at UVA and the study is now enrolling participants at Thomas Jefferson University in Philadelphia as well.